Sale!

RINT1 Gene Breast Cancer NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The RINT1 Gene Breast Cancer NGS Genetic DNA Test is a comprehensive genetic screening that identifies mutations in the RINT1 gene, which is associated with increased hereditary breast cancer risk. This advanced next-generation sequencing test provides crucial information for individuals with family histories of breast cancer, enabling proactive cancer prevention and personalized screening strategies. The test analyzes the entire RINT1 gene sequence to detect pathogenic variants that significantly elevate lifetime breast cancer susceptibility. Results help guide medical management decisions, including enhanced surveillance protocols and risk-reduction interventions. Available for $500 USD, this test offers peace of mind through cutting-edge genetic technology and expert interpretation by certified genetic counselors.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

RINT1 Gene Breast Cancer NGS Genetic DNA Test

Comprehensive Genetic Screening for Hereditary Breast Cancer Risk

The RINT1 Gene Breast Cancer NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment, utilizing advanced next-generation sequencing technology to identify mutations in the RINT1 gene that significantly increase hereditary breast cancer susceptibility. This cutting-edge diagnostic tool provides individuals and families with critical information to guide proactive healthcare decisions and implement targeted prevention strategies.

What Does the RINT1 Gene Test Measure?

This comprehensive genetic analysis specifically targets the RINT1 (RAD50 Interactor 1) gene, which plays a crucial role in DNA damage repair and cell cycle regulation. The test employs sophisticated NGS methodology to sequence the entire RINT1 gene, detecting:

  • Pathogenic variants and mutations associated with increased breast cancer risk
  • Single nucleotide polymorphisms (SNPs) affecting gene function
  • Insertions, deletions, and copy number variations
  • Regulatory region abnormalities impacting gene expression

Who Should Consider RINT1 Genetic Testing?

This test is particularly recommended for individuals with:

  • Personal history of early-onset breast cancer (diagnosed before age 50)
  • Multiple family members with breast cancer across generations
  • Bilateral breast cancer or multiple primary cancers
  • Male breast cancer in the family
  • Ashkenazi Jewish ancestry with breast cancer history
  • Unknown genetic status despite strong family cancer patterns

Key Benefits of RINT1 Genetic Testing

  • Personalized Risk Assessment: Obtain precise information about your hereditary cancer risk profile
  • Proactive Prevention: Implement targeted screening and surveillance protocols
  • Family Planning Guidance: Make informed decisions about genetic inheritance
  • Treatment Optimization: Guide therapeutic decisions based on genetic markers
  • Peace of Mind: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Your RINT1 genetic test results will fall into one of three categories:

  • Positive Result: Indicates the presence of a pathogenic RINT1 mutation, suggesting increased hereditary breast cancer risk. This result enables implementation of enhanced screening protocols and risk-reduction strategies.
  • Negative Result: No RINT1 mutations detected, indicating your breast cancer risk aligns with general population levels. However, continued routine screening remains important.
  • Variant of Uncertain Significance (VUS): Identifies a genetic change with unknown clinical implications. Ongoing research may provide additional clarity over time.

Test Details and Pricing

Test Feature Details
Test Name RINT1 Gene Breast Cancer NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS)

Pre-Test Requirements

Before undergoing RINT1 genetic testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session with certified specialists
  • Development of detailed family pedigree chart
  • Discussion of potential implications and limitations
  • Informed consent process completion

Nationwide Accessibility

General Genetics Corporation maintains testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to cutting-edge genetic testing services regardless of your location.

Take Control of Your Genetic Health Today

Don’t leave your hereditary cancer risk to chance. The RINT1 Gene Breast Cancer NGS Genetic DNA Test provides the clarity and confidence needed to make informed healthcare decisions. Our team of board-certified genetic counselors and oncology specialists are available to guide you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your RINT1 genetic test. Take the first step toward personalized cancer prevention and proactive health management.